Intriguingly, compared to BCC, SCC displays a considerably higher level of phosphorylation of mTOR, thereby exhibiting high sensitivity to mTOR inhibitors (Karayannopoulou et al., 2013; Brinkhuizen et al., 2014). Here, MTOR is linked to skin basal cell carcinoma.